Stellanova Therapeutics rakes in $15.5m Series A
Stellanova Therapeutics Inc, a biotechnology company advancing cancer therapies targeting the tumor microenvironment, has secured $15.5 million in Series A financing.
Stellanova Therapeutics Inc, a biotechnology company advancing cancer therapies targeting the tumor microenvironment, has secured $15.5 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination